NEW YORK — The Trump administration has filed an appeal against a federal judge's order that halted efforts to significantly reduce the number of vaccines recommended for children across the United States, marking the latest escalation in a contentious legal battle over public health policy.
The appeal, submitted on Wednesday to the U.S. Court of Appeals for the First Circuit, comes more than six weeks after U.S. District Judge Brian Murphy issued his ruling on March 16. That order blocked a decision by Health and Human Services Secretary Robert F. Kennedy Jr. to eliminate broad recommendations for vaccinations against the flu, rotavirus, hepatitis A, hepatitis B, certain forms of meningitis, and respiratory syncytial virus (RSV) for all children. The judge's decision also prevented a scheduled meeting of a vaccine advisory committee reconstituted under Kennedy's leadership.
The stay on these changes remains in effect pending the outcome of the appeal, ensuring that the current childhood vaccination schedule stays intact for now. The government's filing was notably brief, consisting of just one sentence requesting the block be lifted, without providing specific reasons. U.S. health officials did not immediately respond to requests for comment on the delay in filing or the substance of the appeal.
This development stems from a lawsuit originally filed in July in federal court in Boston by the American Academy of Pediatrics and several other medical organizations. The initial complaint targeted Kennedy's policy shift to discontinue COVID-19 vaccinations for most children and pregnant women, a move that alarmed pediatricians and public health experts who argued it undermined decades of established immunization guidelines.
As Kennedy, a prominent vaccine skeptic prior to his appointment as the nation's top health official, pursued additional reforms, the plaintiffs amended their suit to address broader concerns. These included the scaling back of the overall childhood vaccination schedule and alterations to the Advisory Committee on Immunization Practices (ACIP), the federal panel that advises the Centers for Disease Control and Prevention on vaccine recommendations.
Last year, Kennedy dismissed the entire 17-member ACIP and appointed a new group that included several individuals known for their anti-vaccine stances. This overhaul prompted the medical groups to seek emergency court intervention, arguing that the changes threatened public health and violated federal procedures for such committees.
Judge Murphy, who was nominated to the federal bench by President Joe Biden in 2022, agreed with the plaintiffs on key points. In his March 16 order, he ruled that Kennedy's reconstitution of the ACIP "likely violated federal law," citing improper appointment processes and conflicts with statutory requirements for the committee's composition. The judge placed all new appointments and any decisions by the revamped panel on hold, effectively restoring the prior status quo.
Earlier this month, the administration attempted to address some of these issues by updating the ACIP's charter. The revisions broadened the qualifications for panel members, potentially allowing the inclusion of more Kennedy allies with diverse viewpoints on vaccines. However, Richard Hughes IV, a lawyer representing the American Academy of Pediatrics, stated that this adjustment did not resolve the underlying legal challenges.
"We are disappointed that the government has chosen to appeal, but we fully expect to prevail," Hughes said in a statement this week. He added a pointed criticism of the administration's approach: "We are committed to bringing an end to Secretary Kennedy's steady destruction of vaccine policy and public health."
The lawsuit's evolution reflects growing tensions between the Trump administration's health policies and the medical establishment. Kennedy, who has long questioned the safety and necessity of certain vaccines, was confirmed as HHS secretary in early 2025 amid promises to "reform" what he described as an overly aggressive vaccination agenda. Critics, including the plaintiffs in this case, contend that his actions prioritize skepticism over scientific consensus, potentially leading to lower immunization rates and increased disease outbreaks.
Supporters of the administration's efforts, though not directly quoted in recent filings, have argued in prior statements that the changes aim to give parents more choice and reduce what they call unnecessary mandates. The ACIP's recommendations, while influential, are not legally binding, but they guide pediatricians, schools, and insurers in promoting vaccinations. Altering them could ripple through state laws and private practices nationwide.
The original lawsuit highlighted specific risks, such as the discontinuation of COVID-19 shots for children over 6 months and pregnant women, which health authorities say has contributed to controlling the virus's spread among vulnerable populations. The broader challenge to the childhood schedule targets vaccines that have been staples since the 1990s and 2000s, credited with dramatic declines in diseases like hepatitis B, which can cause liver cancer, and rotavirus, a leading cause of severe diarrhea in infants.
Judge Murphy's ruling emphasized the procedural flaws in Kennedy's committee overhaul. Federal law requires ACIP members to be selected based on expertise in immunization practices, public health, and related fields, without undue influence from special interests. The judge noted that the new appointees included advocates who have publicly opposed vaccines, raising questions about impartiality.
As the appeal moves forward, legal experts anticipate a review process that could take months, during which the status quo persists. The First Circuit, based in Boston, will hear arguments on whether to lift the stay, potentially setting the stage for a full merits review if the initial bid fails. Meanwhile, the American Academy of Pediatrics has urged Congress to intervene, with leaders testifying in recent hearings about the potential public health fallout.
Beyond the courtroom, this case underscores a larger debate over vaccine policy in the post-pandemic era. With immunization rates already dipping in some areas due to misinformation, medical groups warn that further erosion of recommendations could exacerbate vulnerabilities to preventable diseases. The administration, for its part, maintains that its reforms promote transparency and individual rights, though details on the appeal's strategy remain sparse.
For families navigating pediatric care, the uncertainty lingers. Pediatricians affiliated with the academy continue to follow existing guidelines, advising parents on the full spectrum of vaccines to protect against flu seasons, viral infections, and more. As the legal saga unfolds, public health advocates hope for a swift resolution to safeguard what they view as a cornerstone of child wellness.